Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

Nemolizumab is a new biologic approved to treat atopic dermatitis. In this perspective piece, we use results from our living systematic review and network meta-analysis to provide perspective on the relative efficacy of nemolizumab compared with other approved targeted systemic treatments.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2025-05-07
DOI
https://doi.org/10.1093/bjd/ljaf166
Citations
11
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
22.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

David Prieto‐Merino, B.W.M. Arents, Zenas Z N Yiu, Aaron M. Drucker et al.
11 citations
British Journal of Dermatology
Dermatology and Skin Diseases
22.05
article

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

David Prieto‐Merino, B.W.M. Arents, Zenas Z N Yiu, Aaron M. Drucker, Tim Burton, Sonya Di Giorgio, Carsten Flohr, Bram Rochwerg, Cherry Chu, Tanya Mohan, Jochen Schmitt, Phyllis I. Spuls, Chantel Walwyn
article en
11 citations

Abstract

Nemolizumab is a new biologic approved to treat atopic dermatitis. In this perspective piece, we use results from our living systematic review and network meta-analysis to provide perspective on the relative efficacy of nemolizumab compared with other approved targeted systemic treatments.

British Journal of DermatologyVol. 193(3)
King's College - North Carolina (US), King's College London (GB), University of Toronto (CA), Universidad de Alcalá (ES), Guy's and St Thomas' NHS Foundation Trust (GB), Manchester Academic Health Science Centre (GB), House of Representatives (NL), Salford Royal NHS Foundation Trust (GB), Women's College Hospital (CA), University of Manchester (GB), Salford Royal Hospital (GB), GGD Amsterdam (NL), Impact (CA), University Hospital Carl Gustav Carus (DE), Technische Universität Dresden (DE), McMaster University (CA)
National Eczema Association, Canadian Dermatology Foundation, National Institute for Health and Care Research, National Institutes of Health, Canadian Institutes of Health Research, Medical Research Council
Good health and well-being
Openalex Percentile: Top 0%
Dermatology and Skin Diseases
22.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.